NCT06454175 2025-01-06A Phase I Clinical Trial to Evaluate the Safety of 15-valent HPV Vaccine in Healthy Chinese People Aged 18-45 YearsShanghai Bovax Biotechnology Co., Ltd.Phase 1 Active not recruiting72 enrolled